Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Henriksen

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Bone|October 6, 2018
Alterations in non-type I collagen biomarkers in osteogenesis imperfectaLindsey Nicol, Patrick Morar, Ying Wang, et al.
International Journal of Molecular Sciences|November 9, 2018
A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage FormationYunyun Luo, Yi He, Ditte Reker, et al.
BMC Musculoskeletal Disorders|November 29, 2020
Bone phenotypes in rheumatology - there is more to bone than just boneChristian S Thudium, Signe Holm Nielsen, Samra Sardar, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 22, 2016
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapyMorten A Karsdal, Kim Henriksen, Mette Juul Nielsen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2019
Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogueSamuel J Daniels, Diana J Leeming, Sönke Detlefsen, et al.
Calcified Tissue International|May 20, 2014
A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formationChristian S Thudium, Ilana Moscatelli, Carmen Flores, et al.
European Journal of Pharmacology|May 27, 2014
Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic ratsMichael Feigh, Sara T Hjuler, Kim V Andreassen, et al.
Diabetes/Metabolism Research and Reviews|February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapyKim Henriksen, Inger Byrjalsen, Per Qvist, et al.
Npj Metabolic Health and Disease|July 3, 2025
ECM formation and degradation during fibrosis, repair, and regenerationAlejandro E Mayorca-Guiliani, Diana Julie Leeming, Kim Henriksen, et al.
Bone|October 25, 2020
Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfectaLindsey Nicol, Priya Srikanth, Kim Henriksen, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Bone|October 6, 2018
Alterations in non-type I collagen biomarkers in osteogenesis imperfectaLindsey Nicol, Patrick Morar, Ying Wang, et al.
International Journal of Molecular Sciences|November 9, 2018
A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage FormationYunyun Luo, Yi He, Ditte Reker, et al.
BMC Musculoskeletal Disorders|November 29, 2020
Bone phenotypes in rheumatology - there is more to bone than just boneChristian S Thudium, Signe Holm Nielsen, Samra Sardar, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 22, 2016
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapyMorten A Karsdal, Kim Henriksen, Mette Juul Nielsen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2019
Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogueSamuel J Daniels, Diana J Leeming, Sönke Detlefsen, et al.
Calcified Tissue International|May 20, 2014
A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formationChristian S Thudium, Ilana Moscatelli, Carmen Flores, et al.
European Journal of Pharmacology|May 27, 2014
Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic ratsMichael Feigh, Sara T Hjuler, Kim V Andreassen, et al.
Diabetes/Metabolism Research and Reviews|February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapyKim Henriksen, Inger Byrjalsen, Per Qvist, et al.
Npj Metabolic Health and Disease|July 3, 2025
ECM formation and degradation during fibrosis, repair, and regenerationAlejandro E Mayorca-Guiliani, Diana Julie Leeming, Kim Henriksen, et al.
Bone|October 25, 2020
Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfectaLindsey Nicol, Priya Srikanth, Kim Henriksen, et al.
Pageof 16